Cargando…
Mir142 loss unlocks IDH2(R140)-dependent leukemogenesis through antagonistic regulation of HOX genes
AML is a genetically heterogeneous disease and understanding how different co-occurring mutations cooperate to drive leukemogenesis will be crucial for improving diagnostic and therapeutic options for patients. MIR142 mutations have been recurrently detected in IDH-mutated AML samples. Here, we have...
Autores principales: | Marshall, A., Kasturiarachchi, J., Datta, P., Guo, Y., Deltcheva, E., James, C., Brown, J., May, G., Anandagoda, N., Jackson, I., Howard, J. K., Ghazaly, E., Brooks, S., Khwaja, A., Araki, M., Araki, K., Linch, D., Lord, G. M., Enver, T., Nimmo, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656267/ https://www.ncbi.nlm.nih.gov/pubmed/33173219 http://dx.doi.org/10.1038/s41598-020-76218-8 |
Ejemplares similares
-
Author Correction: Mir142 loss unlocks IDH2(R140)-dependent leukemogenesis through antagonistic regulation of HOX genes
por: Marshall, A., et al.
Publicado: (2021) -
MicroRNA-142 Critically Regulates Group 2 Innate Lymphoid Cell Homeostasis and Function
por: Roberts, Luke B., et al.
Publicado: (2021) -
Regulation of CDX4 gene transcription by HoxA9, HoxA10, the Mll-Ell oncogene and Shp2 during leukemogenesis
por: Bei, L, et al.
Publicado: (2014) -
A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice
por: Kawano, Shingo, et al.
Publicado: (2023) -
microRNA-142–mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance
por: Anandagoda, Nelomi, et al.
Publicado: (2019)